MNOV
MediciNovaBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
MNOV vs peer average
79/100
MNOV vs. peer average (B vs. D)
Grade spread
A 1 · B 1 · C 2 · D 1 · F 5
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ATHE is the first available peer comparator.
Alterity is a similarly micro-cap clinical-stage neurology biotech where valuation is driven more by trial milestones and financing capacity than current revenue, making it a reasonably direct event-volatility peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
MNOV
MediciNova
ATHE
Alterity Therapeutics
Grade
B
F
Momentum
85
13
Value
41
41
Sentiment
51
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs ATHE
MNOV / ATHE
Grade Position
Above peers
MNOV vs. peer average (B vs. D)
79/100
Momentum
85
MNOVValue
41
MNOVSentiment
51
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs MNOV
ATHE is the first peer returned for this comparison set.